Tuesday, February 17, 2009

Lilly to Develop Treatments With Danish Company

Indianapolis-based Eli Lilly and Co. is partnering with Danish biotech firm NeuroSearch to develop medicines for treating central nervous system disorders, reports Inside INdiana Business.

Under the three-year deal NeuroSearch could receive as much as $30 million in initial payments and research funding and up to $320 million in milestone fees for each product developed and commercialized.


No comments: